Woodline Partners LP
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1784547
San Francisco, CA
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,710,171
-$21,017,539 QoQ
Shares Held
700,929
-37.2% QoQ
Ownership
0.680%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. VRDN ranks #65 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | QNCX |
Quince Therapeutics, Inc.
|
5,200,000 | $105,040,000 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 |
All Filings in VRDN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,710,171 | 700,929 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,727,710 | 1,115,929 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,598,166 | 815,485 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,400,480 | 815,485 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,967,961 | 813,647 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,597,612 | 813,647 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,632,136 | 818,995 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,215,904 | 400,915 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,685,524 | 438,922 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $3,998,147 | 168,060 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,038,782 | 119,449 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,468,100 | 324,139 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,068,375 | 295,874 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,390,932 | 552,371 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,091,041 | 221,257 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,094,135 | 257,670 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||